Prevalence and Risk of Polypharmacy Among Community-Dwelling, Elderly Kuwaiti Patients.
To estimate the prevalence of polypharmacy in community-dwelling, older Kuwaiti patients, describe the number and types of drugs used and to identify risk factors associated with polypharmacy. This was a descriptive cross-sectional questionnaire-based survey in which we interviewed 500 community-dwelling, Kuwaiti adults over 65 years of age. The data collection occurred during a four-month period from March to July 2017. Fifty-two percent (n = 260) of the patients were males, with a mean age of 71.73 ± 5.32 years. The prevalence of polypharmacy (5-8 drugs) and excessive polypharmacy (> 8 drugs) were 58.4% (n = 292) and 10.2% (n = 51) respectively. The risk factors associated with an increased number of used medicines were female gender (p = 0.019), a lower level of education (p = 0.003), and a high number of hospital admissions (p =0.000), clinics visited by the patient (p = 0.000), and number of comorbidities (p = 0.000). The most commonly used medications were blood glucose-lowering agents excluding insulin, which were used by 82.6% of the study population. Other commonly used medications were antihypertensive drugs and lipid-modifying agents. A significant sector of the older Kuwaiti patient population has a high prevalence of polypharmacy and thus are exposed to its potential hazards. The current study highlights the need to revise the drug-dispensing policy among community-dwelling, older Kuwaiti people, as well as to initiate educational programs among healthcare practitioners concerning prescribing issues in older individuals.